Cargando…

Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies

The microenvironment possesses a strong impact on the tumor chemoresistance when cells bind to components of the extracellular matrix. Here we elucidate the signaling pathways of cisplatin resistance in W1 ovarian cancer cells binding to collagen type 1 (COL1) and signaling interference with constit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wantoch von Rekowski, Kathleen, König, Philipp, Henze, Svenja, Schlesinger, Martin, Zawierucha, Piotr, Januchowski, Radosław, Bendas, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730285/ https://www.ncbi.nlm.nih.gov/pubmed/33287446 http://dx.doi.org/10.3390/ijms21239240

Ejemplares similares

The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells
por: Wantoch von Rekowski, Kathleen, et al.
Publicado: (2019)

The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers—Preclinical In Vivo Evaluation in Xenograft Tumor Models
por: Mueller, Thomas, et al.
Publicado: (2017)

Mechanisms of Matrix-Induced Chemoresistance of Breast Cancer Cells—Deciphering Novel Potential Targets for a Cell Sensitization
por: Jakubzig, Bastian, et al.
Publicado: (2018)

Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β(1)-Integrin Emerges as a Key Factor for Breast Cancer Chemosensitization upon Collagen Type 1 Binding
por: Baltes, Fabian, et al.
Publicado: (2020)

Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line
por: Januchowski, Radosław, et al.
Publicado: (2014)

A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis
por: König, Philipp, et al.
Publicado: (2023)

Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway
por: Pfankuchen, Daniel Bastian, et al.
Publicado: (2017)

The GPIb-IX complex on platelets: insight into its novel physiological functions affecting immune surveillance, hepatic thrombopoietin generation, platelet clearance and its relevance for cancer development and metastasis
por: Bendas, Gerd, et al.
Publicado: (2022)

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
por: Wu, Chunjing, et al.
Publicado: (2005)

The Low Molecular Weight Heparin Tinzaparin Attenuates Platelet Activation in Terms of Metastatic Niche Formation by Coagulation-Dependent and Independent Pathways
por: Gockel, Lukas Maria, et al.
Publicado: (2018)

The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation
por: Ponert, Jan Moritz, et al.
Publicado: (2018)

Glycosaminoglycans as Tools to Decipher the Platelet Tumor Cell Interaction: A Focus on P-Selectin
por: Schwarz, Svenja, et al.
Publicado: (2020)

Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers
por: Yoo, Hawon, et al.
Publicado: (2021)

Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells
por: Kim, Hyung Joon, et al.
Publicado: (2020)

HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells
por: Lu, Hao, et al.
Publicado: (2016)

Transportan 10 improves the anticancer activity of cisplatin
por: Izabela, Rusiecka, et al.
Publicado: (2016)

Elevated expression of HSP90 and the antitumor effect of an HSP90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma
por: Bekki, Hirofumi, et al.
Publicado: (2015)

Integrin Activation Contributes to Lower Cisplatin Sensitivity in MV3 Melanoma Cells by Inducing the Wnt Signalling Pathway
por: Piva, Maria B. R., et al.
Publicado: (2017)

A Combined Activity of Thrombin and P-Selectin Is Essential for Platelet Activation by Pancreatic Cancer Cells
por: Haschemi, Reza, et al.
Publicado: (2021)

Erratum to: Transportan 10 improves the anticancer activity of cisplatin
por: Rusiecka, Izabela, et al.
Publicado: (2016)

Expressions of HSP70 and HSP27 in Hepatocellular Carcinoma
por: Joo, Mee, et al.
Publicado: (2005)

Hsp27 and Hsp70 Expression in Esophageal Squamous
por: Luz, Caio Cesar Floriano, et al.
Publicado: (2017)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016)

AMPK/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury
por: Wang, Ying, et al.
Publicado: (2020)

Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells
por: Duan, Jingya, et al.
Publicado: (2023)

Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines
por: Januchowski, Radosław, et al.
Publicado: (2017)

Hsp27-Actin Interaction
por: Graceffa, Philip
Publicado: (2011)

Down-regulation of HSP60 Suppresses the Proliferation of Glioblastoma Cells via the ROS/AMPK/mTOR Pathway
por: Tang, Haiping, et al.
Publicado: (2016)

Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70
por: Gao, Shanshan, et al.
Publicado: (2020)

The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines
por: Kazmierczak, Dominika, et al.
Publicado: (2022)

Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules
por: Kim, Jee Hye, et al.
Publicado: (2016)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition
por: Jin, H-O, et al.
Publicado: (2012)

Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
por: Hou, Guiqin, et al.
Publicado: (2014)

Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway
por: Wu, Tao, et al.
Publicado: (2015)

miR-7 Increases Cisplatin Sensitivity of Gastric Cancer Cells Through Suppressing mTOR
por: Xu, Ning, et al.
Publicado: (2017)

STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma
por: Morelli, Ana Paula, et al.
Publicado: (2021)

Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways
por: Guo, Liemei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_todoa27ne03rsncdlusb5quo7r